141.74MMarket Cap-2077P/E (TTM)
1.960High1.840Low2.89MVolume1.900Open1.740Pre Close5.52MTurnover3.91%Turnover RatioLossP/E (Static)75.80MShares2.50052wk High1.74P/B138.02MFloat Cap1.08052wk Low--Dividend TTM73.81MShs Float396.060Historical High--Div YieldTTM6.90%Amplitude1.080Historical Low1.913Avg Price1Lot Size
aTyr Pharma Stock Forum
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
Post hoc analysis of Phase 1b/2a study demonstrated statistically significant difference in time-to-first-relapse for corticosteroid use in therapeutic (3.0 and 5.0 mg/kg efzofitimod) vs subtherapeutic (1.0 mg/kg efzofitimod and placebo) groups.
54.4% of patients in the subtherapeutic group relapsed following corticosteroid taper, compar...
No comment yet